Stock Price
1.30
Daily Change
0.05 4.00%
Monthly
18.18%
Yearly
8.33%
Q2 Forecast
1.22

Actinium Pharmaceuticals reported $31.2M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Actinium Pharmaceuticals USD 31.2M 0 Sep/2025
Amgen USD 539M 1000K Dec/2025
Bioline Rx USD 2.61B 53.2M Sep/2025
Capricor Therapeutics USD 57.37M 11.65M Dec/2025
Pfizer USD 5.69B 1000K Sep/2025